Etaracizumab (Anti-Integrin aVb3 (ITGAV & ITGB3))

Etaracizumab (Anti-Integrin aVb3 (ITGAV & ITGB3)) is an IgG1 monoclonal antibody targeting αvβ3 integrin. It inhibits angiogenesis and melanoma tumor growth and can be used to research anticancer. MW :144.18 KD.
Supplier Selleck Chemicals
Product # A2991
Sku # A2991-1mg*5
Pricing 1mg*5, $970.00
Feedback